Wellcome Sanger Institute, Hinxton, UK.
Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany.
Nat Genet. 2023 Nov;55(11):1892-1900. doi: 10.1038/s41588-023-01545-1. Epub 2023 Oct 26.
Somatic mutations are hypothesized to play a role in many non-neoplastic diseases. We performed whole-exome sequencing of 1,182 microbiopsies dissected from lesional and nonlesional epidermis from 111 patients with psoriasis to search for evidence that somatic mutations in keratinocytes may influence the disease process. Lesional skin remained highly polyclonal, showing no evidence of large-scale spread of clones carrying potentially pathogenic mutations. The mutation rate of keratinocytes was similarly only modestly affected by the disease. We found evidence of positive selection in previously reported driver genes NOTCH1, NOTCH2, TP53, FAT1 and PPM1D and also identified mutations in four genes (GXYLT1, CHEK2, ZFP36L2 and EEF1A1) that we hypothesize are selected for in squamous epithelium irrespective of disease status. Finally, we describe a mutational signature of psoralens-a class of chemicals previously found in some sunscreens and which are used as part of PUVA (psoralens and ultraviolet-A) photochemotherapy treatment for psoriasis.
体细胞突变被认为在许多非肿瘤性疾病中发挥作用。我们对 111 名银屑病患者的皮损和非皮损表皮的 1182 个活检组织进行了全外显子组测序,以寻找角质形成细胞中的体细胞突变可能影响疾病进程的证据。皮损皮肤仍然高度呈多克隆性,没有携带潜在致病突变的克隆大规模扩散的证据。角质形成细胞的突变率也仅受到疾病的轻微影响。我们在先前报道的驱动基因 NOTCH1、NOTCH2、TP53、FAT1 和 PPM1D 中发现了正选择的证据,并且还鉴定了四个基因(GXYLT1、CHEK2、ZFP36L2 和 EEF1A1)的突变,我们假设这些突变在鳞状上皮中是不受疾病状态选择的。最后,我们描述了一种光化学疗法治疗银屑病时使用的补骨脂素(一类先前在某些防晒霜中发现的化学物质)的突变特征。